{"rows":[{"id":5964,"title":"MedCheck: Drugmakers Advance Psilocybin, Oral Pregnanolone for MDD, Plus FDA Approves Pediatric Tourette's Drug, and More","authors":"Richmond Linda M.","journal":"Psychiatric News","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1176/appi.pn.2026.10.10.1","pubmed_id":null,"openalex_id":"https://openalex.org/W7214993352","source_url":"https://doi.org/10.1176/appi.pn.2026.10.10.1","substance_tags":"psilocybin","topic_tags":"Depression","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-10-01 01:20:23","last_checked":"2026-10-08 01:20:19","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2026.10.10.1","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1176/appi.pn.2026.10.10.1","source_url":"https://doi.org/10.1176/appi.pn.2026.10.10.1","doi":"10.1176/appi.pn.2026.10.10.1","pmid":"","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5763,"title":"One Dose of Psilocybin May Alter Brain Structure","authors":"Karel Richard B.","journal":"Psychiatric News","publication_date":"2026-08-01","publication_year":2026,"doi":"10.1176/appi.pn.2026.08.8.12","pubmed_id":null,"openalex_id":"https://openalex.org/W7171863228","source_url":"https://doi.org/10.1176/appi.pn.2026.08.8.12","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-08-01 01:20:18","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2026.08.8.12","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1176/appi.pn.2026.08.8.12","source_url":"https://doi.org/10.1176/appi.pn.2026.08.8.12","doi":"10.1176/appi.pn.2026.08.8.12","pmid":"","publication_date":"2026-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5331,"title":"Study Suggests Hallucinogen May Be Personality Changer","authors":"Joan Arehart-Treichel","journal":"Psychiatric News","publication_date":"2011-12-16","publication_year":2011,"doi":"10.1176/pn.46.24.psychnews_46_24_19-a","pubmed_id":null,"openalex_id":"https://openalex.org/W1977816893","source_url":"https://doi.org/10.1176/pn.46.24.psychnews_46_24_19-a","substance_tags":"psilocybin","topic_tags":"Personality Change,Spirituality,Mystical Experience","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:05","last_checked":"2026-08-09 08:25:54","bibtex":null,"source_record_id":"DOI:10.1176/pn.46.24.psychnews_46_24_19-a","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/pn.46.24.psychnews_46_24_19-a","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/pn.46.24.psychnews_46_24_19-a","source_url":"https://doi.org/10.1176/pn.46.24.psychnews_46_24_19-a","doi":"10.1176/pn.46.24.psychnews_46_24_19-a","pmid":"","publication_date":"2011-12-16","importer_version":"2.1.3","text_redistributed":false}},{"id":5119,"title":"Session on Psychedelics Sure to Be Enlightening","authors":"Nick Zagorski","journal":"Psychiatric News","publication_date":"2021-03-01","publication_year":2021,"doi":"10.1176/appi.pn.2021.3.14","pubmed_id":null,"openalex_id":"https://openalex.org/W3133604748","source_url":"https://doi.org/10.1176/appi.pn.2021.3.14","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Consciousness,Wellbeing,Emotional Processing,Review Article,Cancer Patients,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:00","last_checked":"2026-08-09 08:25:46","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2021.3.14","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2021.3.14","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2021.3.14","source_url":"https://doi.org/10.1176/appi.pn.2021.3.14","doi":"10.1176/appi.pn.2021.3.14","pmid":"","publication_date":"2021-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5115,"title":"The Return of Psychedelics: Still Time to Prevent Tragedy","authors":"Stanley N. Caroff","journal":"Psychiatric News","publication_date":"2021-03-31","publication_year":2021,"doi":"10.1176/appi.pn.2021.4.8","pubmed_id":null,"openalex_id":"https://openalex.org/W3147930394","source_url":"https://doi.org/10.1176/appi.pn.2021.4.8","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Headache / Migraine,Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Case Report,Observational Study,Adolescents,Safety,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:59","last_checked":"2026-08-09 08:25:46","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2021.4.8","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2021.4.8","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2021.4.8","source_url":"https://doi.org/10.1176/appi.pn.2021.4.8","doi":"10.1176/appi.pn.2021.4.8","pmid":"","publication_date":"2021-03-31","importer_version":"2.1.3","text_redistributed":false}},{"id":5075,"title":"Psychedelic Therapy Hits Another Milestone, But Caution Urged","authors":"Nick Zagorski","journal":"Psychiatric News","publication_date":"2021-07-22","publication_year":2021,"doi":"10.1176/appi.pn.2021.7.14","pubmed_id":null,"openalex_id":"https://openalex.org/W3193219878","source_url":"https://doi.org/10.1176/appi.pn.2021.7.14","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Review Article,Cancer Patients,Healthcare Workers,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:59","last_checked":"2026-08-09 08:25:45","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2021.7.14","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2021.7.14","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2021.7.14","source_url":"https://doi.org/10.1176/appi.pn.2021.7.14","doi":"10.1176/appi.pn.2021.7.14","pmid":"","publication_date":"2021-07-22","importer_version":"2.1.3","text_redistributed":false}},{"id":5045,"title":"Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea","authors":"David J. Hellerstein, Kevin A. Sabet, Jeffrey A. Lieberman","journal":"Psychiatric News","publication_date":"2021-11-29","publication_year":2021,"doi":"10.1176/appi.pn.2021.12.14","pubmed_id":null,"openalex_id":"https://openalex.org/W3216344082","source_url":"https://doi.org/10.1176/appi.pn.2021.12.14","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Consciousness,Mystical Experience,Review Article,Adolescents,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:44","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2021.12.14","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2021.12.14","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2021.12.14","source_url":"https://doi.org/10.1176/appi.pn.2021.12.14","doi":"10.1176/appi.pn.2021.12.14","pmid":"","publication_date":"2021-11-29","importer_version":"2.1.3","text_redistributed":false}},{"id":5041,"title":"Marijuana, Hallucinogen Use Reach Historic Levels Among Young Adults","authors":"Linda M. Richmond","journal":"Psychiatric News","publication_date":"2021-11-30","publication_year":2021,"doi":"10.1176/appi.pn.2021.11.29","pubmed_id":null,"openalex_id":"https://openalex.org/W3216860842","source_url":"https://doi.org/10.1176/appi.pn.2021.11.29","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Spirituality,Mystical Experience,Observational Study,Safety","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:58","last_checked":"2026-08-09 08:25:44","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2021.11.29","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2021.11.29","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2021.11.29","source_url":"https://doi.org/10.1176/appi.pn.2021.11.29","doi":"10.1176/appi.pn.2021.11.29","pmid":"","publication_date":"2021-11-30","importer_version":"2.1.3","text_redistributed":false}},{"id":4980,"title":"Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?","authors":"Michael Avissar, Adrian Jacques H. Ambrose","journal":"Psychiatric News","publication_date":"2022-03-24","publication_year":2022,"doi":"10.1176/appi.pn.2022.04.4.35","pubmed_id":null,"openalex_id":"https://openalex.org/W4220982704","source_url":"https://doi.org/10.1176/appi.pn.2022.04.4.35","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,End-of-Life Distress,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:57","last_checked":"2026-08-09 08:25:42","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2022.04.4.35","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2022.04.4.35","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2022.04.4.35","source_url":"https://doi.org/10.1176/appi.pn.2022.04.4.35","doi":"10.1176/appi.pn.2022.04.4.35","pmid":"","publication_date":"2022-03-24","importer_version":"2.1.3","text_redistributed":false}},{"id":4967,"title":"Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits","authors":"Richard Karel","journal":"Psychiatric News","publication_date":"2022-05-23","publication_year":2022,"doi":"10.1176/appi.pn.2022.06.6.30","pubmed_id":null,"openalex_id":"https://openalex.org/W4281400661","source_url":"https://doi.org/10.1176/appi.pn.2022.06.6.30","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Pharmacology,Consciousness,Wellbeing,Spirituality,Mystical Experience,Observational Study,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:57","last_checked":"2026-08-09 08:25:42","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2022.06.6.30","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2022.06.6.30","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2022.06.6.30","source_url":"https://doi.org/10.1176/appi.pn.2022.06.6.30","doi":"10.1176/appi.pn.2022.06.6.30","pmid":"","publication_date":"2022-05-23","importer_version":"2.1.3","text_redistributed":false}},{"id":4946,"title":"Med Check: Psilocybin for OCD, Nuplazid Vote, and More","authors":"Terri D’Arrigo","journal":"Psychiatric News","publication_date":"2022-08-01","publication_year":2022,"doi":"10.1176/appi.pn.2022.08.8.2","pubmed_id":null,"openalex_id":"https://openalex.org/W4289781881","source_url":"https://doi.org/10.1176/appi.pn.2022.08.8.2","substance_tags":"psilocybin","topic_tags":"Depression,OCD,Headache / Migraine,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:51:57","last_checked":"2026-08-09 08:25:41","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2022.08.8.2","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2022.08.8.2","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2022.08.8.2","source_url":"https://doi.org/10.1176/appi.pn.2022.08.8.2","doi":"10.1176/appi.pn.2022.08.8.2","pmid":"","publication_date":"2022-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4894,"title":"Depression Improves Following Single Dose of Psilocybin","authors":"Nick Zagorski","journal":"Psychiatric News","publication_date":"2022-12-26","publication_year":2022,"doi":"10.1176/appi.pn.2023.01.1.50","pubmed_id":null,"openalex_id":"https://openalex.org/W4312194249","source_url":"https://doi.org/10.1176/appi.pn.2023.01.1.50","substance_tags":"psilocybin","topic_tags":"Depression,Randomized Controlled Trial,Treatment-Resistant Depression,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:47","last_checked":"2026-08-09 08:25:38","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2023.01.1.50","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2023.01.1.50","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2023.01.1.50","source_url":"https://doi.org/10.1176/appi.pn.2023.01.1.50","doi":"10.1176/appi.pn.2023.01.1.50","pmid":"","publication_date":"2022-12-26","importer_version":"2.1.3","text_redistributed":false}},{"id":4846,"title":"Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First","authors":"Jacques Ambrose, J.S. Zabinski","journal":"Psychiatric News","publication_date":"2023-02-16","publication_year":2023,"doi":"10.1176/appi.pn.2023.03.3.43","pubmed_id":null,"openalex_id":"https://openalex.org/W4321033113","source_url":"https://doi.org/10.1176/appi.pn.2023.03.3.43","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:37","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2023.03.3.43","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2023.03.3.43","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2023.03.3.43","source_url":"https://doi.org/10.1176/appi.pn.2023.03.3.43","doi":"10.1176/appi.pn.2023.03.3.43","pmid":"","publication_date":"2023-02-16","importer_version":"2.1.3","text_redistributed":false}},{"id":4845,"title":"Psychedelics Legislation Gains Momentum","authors":"Terri D’Arrigo","journal":"Psychiatric News","publication_date":"2023-02-16","publication_year":2023,"doi":"10.1176/appi.pn.2023.03.3.4","pubmed_id":null,"openalex_id":"https://openalex.org/W4321017755","source_url":"https://doi.org/10.1176/appi.pn.2023.03.3.4","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Receptor Pharmacology,Safety,Drug Interactions","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:37","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2023.03.3.4","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2023.03.3.4","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2023.03.3.4","source_url":"https://doi.org/10.1176/appi.pn.2023.03.3.4","doi":"10.1176/appi.pn.2023.03.3.4","pmid":"","publication_date":"2023-02-16","importer_version":"2.1.3","text_redistributed":false}},{"id":4830,"title":"Experts to Discuss the Ethics of Psychedelics","authors":"Terri D’Arrigo","journal":"Psychiatric News","publication_date":"2023-03-27","publication_year":2023,"doi":"10.1176/appi.pn.2023.04.3.10","pubmed_id":null,"openalex_id":"https://openalex.org/W4361025669","source_url":"https://doi.org/10.1176/appi.pn.2023.04.3.10","substance_tags":"psilocybin","topic_tags":"Addiction","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:36","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2023.04.3.10","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2023.04.3.10","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2023.04.3.10","source_url":"https://doi.org/10.1176/appi.pn.2023.04.3.10","doi":"10.1176/appi.pn.2023.04.3.10","pmid":"","publication_date":"2023-03-27","importer_version":"2.1.3","text_redistributed":false}},{"id":4803,"title":"Experts Offer Tips on Talking With Patients About Psychedelics","authors":"Terri D’Arrigo","journal":"Psychiatric News","publication_date":"2023-06-28","publication_year":2023,"doi":"10.1176/appi.pn.2023.07.7.51","pubmed_id":null,"openalex_id":"https://openalex.org/W4382360061","source_url":"https://doi.org/10.1176/appi.pn.2023.07.7.51","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Veterans,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:45","last_checked":"2026-08-09 08:25:35","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2023.07.7.51","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2023.07.7.51","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2023.07.7.51","source_url":"https://doi.org/10.1176/appi.pn.2023.07.7.51","doi":"10.1176/appi.pn.2023.07.7.51","pmid":"","publication_date":"2023-06-28","importer_version":"2.1.3","text_redistributed":false}},{"id":4802,"title":"Psychedelic Therapy Requires Enhanced Consent Discussions","authors":"Nick Zagorski","journal":"Psychiatric News","publication_date":"2023-06-28","publication_year":2023,"doi":"10.1176/appi.pn.2023.07.7.46","pubmed_id":null,"openalex_id":"https://openalex.org/W4382360046","source_url":"https://doi.org/10.1176/appi.pn.2023.07.7.46","substance_tags":"psilocybin","topic_tags":"Anxiety,Receptor Pharmacology,Consciousness,Spirituality,Observational Study,Healthcare Workers,Safety","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:45","last_checked":"2026-08-09 08:25:35","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2023.07.7.46","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2023.07.7.46","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2023.07.7.46","source_url":"https://doi.org/10.1176/appi.pn.2023.07.7.46","doi":"10.1176/appi.pn.2023.07.7.46","pmid":"","publication_date":"2023-06-28","importer_version":"2.1.3","text_redistributed":false}},{"id":4791,"title":"Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and Lumryz","authors":"Terri D’Arrigo","journal":"Psychiatric News","publication_date":"2023-07-27","publication_year":2023,"doi":"10.1176/appi.pn.2023.08.8.3","pubmed_id":null,"openalex_id":"https://openalex.org/W4385324763","source_url":"https://doi.org/10.1176/appi.pn.2023.08.8.3","substance_tags":"psilocybin","topic_tags":"Addiction,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Safety,Immune Function","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:45","last_checked":"2026-08-09 08:25:35","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2023.08.8.3","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2023.08.8.3","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2023.08.8.3","source_url":"https://doi.org/10.1176/appi.pn.2023.08.8.3","doi":"10.1176/appi.pn.2023.08.8.3","pmid":"","publication_date":"2023-07-27","importer_version":"2.1.3","text_redistributed":false}},{"id":4786,"title":"Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy","authors":"Nick Zagorski","journal":"Psychiatric News","publication_date":"2023-08-15","publication_year":2023,"doi":"10.1176/appi.pn.2023.09.9.20","pubmed_id":null,"openalex_id":"https://openalex.org/W4385829163","source_url":"https://doi.org/10.1176/appi.pn.2023.09.9.20","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Mechanism of Action,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:45","last_checked":"2026-08-09 08:25:35","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2023.09.9.20","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2023.09.9.20","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2023.09.9.20","source_url":"https://doi.org/10.1176/appi.pn.2023.09.9.20","doi":"10.1176/appi.pn.2023.09.9.20","pmid":"","publication_date":"2023-08-15","importer_version":"2.1.3","text_redistributed":false}},{"id":4663,"title":"Psychedelic Renaissance: Evidence and Culture","authors":"Adrian Preda","journal":"Psychiatric News","publication_date":"2024-03-21","publication_year":2024,"doi":"10.1176/appi.pn.2024.04.4.39","pubmed_id":null,"openalex_id":"https://openalex.org/W4393030764","source_url":"http://dx.doi.org/10.1176/appi.pn.2024.04.4.39","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Neuroplasticity,Emotional Processing,Spirituality,Clinical Trial,Animal Study,Healthcare Workers,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:30","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2024.04.4.39","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"http://dx.doi.org/10.1176/appi.pn.2024.04.4.39","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2024.04.4.39","source_url":"http://dx.doi.org/10.1176/appi.pn.2024.04.4.39","doi":"10.1176/appi.pn.2024.04.4.39","pmid":"","publication_date":"2024-03-21","importer_version":"2.1.3","text_redistributed":false}}],"total":33,"page":1,"per_page":20,"pages":2,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Psychiatric News","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}